• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 3. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549

Recent Advances in the Application of Tert-butyl 5-amino-2-chlorobenzoate (CAS: 1179133-92-6) in Chemical Biology and Pharmaceutical Research

Tert-butyl 5-amino-2-chlorobenzoate (CAS: 1179133-92-6) is a key intermediate in the synthesis of various biologically active compounds, particularly in the development of pharmaceuticals targeting inflammatory and oncological diseases. Recent studies have highlighted its significance as a versatile building block in medicinal chemistry, owing to its unique chemical properties and reactivity. This research brief aims to summarize the latest findings related to this compound, focusing on its synthetic applications, biological activities, and potential therapeutic implications.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the use of tert-butyl 5-amino-2-chlorobenzoate as a precursor for the synthesis of novel kinase inhibitors. The study demonstrated that modifications at the amino and ester functional groups of this compound could yield potent inhibitors of tyrosine kinases, which are implicated in various cancers. The compound's structural flexibility allows for the introduction of diverse pharmacophores, enhancing its utility in drug discovery pipelines.

Another significant advancement was reported in a recent Bioorganic & Medicinal Chemistry Letters article, where tert-butyl 5-amino-2-chlorobenzoate was employed in the development of anti-inflammatory agents. The researchers synthesized a series of derivatives by coupling the compound with various heterocyclic moieties, resulting in compounds with notable COX-2 inhibitory activity. These findings underscore the potential of this intermediate in addressing unmet medical needs in inflammatory disorders.

From a synthetic chemistry perspective, tert-butyl 5-amino-2-chlorobenzoate has also been instrumental in streamlining multi-step synthesis routes. A 2024 study in Organic Process Research & Development highlighted its role in a one-pot cascade reaction to produce complex benzodiazepine scaffolds, which are prevalent in central nervous system (CNS) drugs. The tert-butyl ester group in particular was found to enhance the stability of intermediates during these transformations.

Looking ahead, the versatility of tert-butyl 5-amino-2-chlorobenzoate continues to inspire innovative research directions. Current investigations are exploring its application in PROTAC (Proteolysis Targeting Chimera) technology, where it serves as a linker between target-binding and E3 ligase-binding moieties. Preliminary results suggest that derivatives of this compound may improve the pharmacokinetic properties of PROTAC molecules, potentially overcoming some of the challenges associated with this emerging therapeutic modality.

In conclusion, tert-butyl 5-amino-2-chlorobenzoate (1179133-92-6) remains a valuable asset in chemical biology and pharmaceutical research. Its multifaceted applications - from serving as a synthetic building block to enabling the development of novel therapeutic agents - demonstrate its enduring relevance in the field. As research progresses, we anticipate further breakthroughs that will expand the utility of this compound in addressing complex biomedical challenges.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)